Enovix Corporation (ENVX) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reveals strong financial metrics and optimistic guidance, particularly with a 25% revenue increase expected and significant market expansion in smartphones, smart eyewear, and defense. Despite some uncertainties in the Q&A, like the 0.7C test for smartphones, the overall sentiment is positive due to new product launches, strategic partnerships, and manufacturing optimizations. The market cap suggests moderate sensitivity, leading to a positive prediction of stock movement between 2% to 8%.
Key Financial Performance
Full Year 2025 Revenue $31.8 million, a 38% year-over-year increase. This growth was driven by sustained execution in defense and industrial markets.
Full Year Non-GAAP Gross Margin 23%, reflecting an improvement due to higher production volumes and a favorable mix shift towards higher-margin defense batteries following an April 2025 asset acquisition.
Cash, Cash Equivalents, and Marketable Securities at Year-End $621 million, supporting qualification completion, commercial scale-up, and potential strategic transactions.
Fourth Quarter 2025 Revenue $11.3 million, a 16% year-over-year increase, driven by continued strength in defense and industrial shipments out of Korea.
Fourth Quarter Non-GAAP Gross Margin 26%, benefiting from higher volumes and operational improvements in Korea.
Full Year Non-GAAP Loss from Operations $28.9 million, better than the guidance range of $30 million to $33 million, reflecting continued investment in smartphone and smart eyewear qualification programs as well as Fab2 readiness.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
AI-1 platform for smartphones: Continued advancing smartphone qualification with lead mobile customer.
Smart eyewear batteries: Preparing production to support initial high-volume demand for lead smart eyewear customer.
Defense batteries: Top product in Q4 was batteries for naval munitions.
Smart eyewear market: Expected to grow significantly, with battery TAM exceeding $400 million by 2030.
Drone market: Battery TAM projected at $1.5 billion in 2026, with focus on higher energy density and extended flight time.
Operational leadership: Strengthened with new hires, including KH leading global manufacturing and Ed Casey for advanced manufacturing engineering.
Fab2 production: Improved yield and throughput, addressing laser dicing constraints.
Strategic market focus: Expanding into smartphones, smart eyewear, and defense applications.
Share repurchase program: Authorized to enhance shareholder value.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Smartphone Qualification Challenges: Cycle life testing remains a primary gating item for smartphone qualification. The batteries are not currently on track to meet the accelerated 0.7C target, which is a critical requirement for qualification. This could delay commercialization and revenue generation in the smartphone market.
Manufacturing Constraints: Zone 1 laser dicing remains the primary rate-limiting factor in production. This bottleneck could hinder the company's ability to scale up manufacturing and meet high-volume production demands.
Defense Market Dependency: The company’s largest revenue contributor is defense shipments, particularly naval munitions. Over-reliance on this segment could pose risks if demand fluctuates or contracts.
Capital Expenditure Adjustments: Delays in the initiation of the NPI line in Korea and adjustments to capital plans could impact the timeline for scaling manufacturing capabilities.
Regulatory and Qualification Barriers: High qualification standards in the smartphone market and undefined testing protocols for 100% silicon anode batteries could delay market entry and revenue realization.
Economic and Market Risks: Seasonality and program timing in defense shipments could lead to revenue fluctuations, impacting financial stability.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Smartphone Commercialization: Enovix is engaged with 7 of the top 8 global smartphone OEMs, with Honor as the lead customer. Initial smartphone-related revenue in 2026 is expected to support system integration and launch preparation, with larger-scale commercialization anticipated in late 2026 or early 2027.
Smart Eyewear Market: Smart eyewear is identified as an earlier commercialization pathway for the AI-1 platform. Initial volume shipments to lead smart eyewear platforms are expected later in 2026. The smart eyewear battery TAM is projected to exceed $400 million by 2030, with significant growth expected throughout the decade.
Defense and Drone Applications: The defense segment has a global pipeline of approximately $100 million, with opportunities involving Tier 1 defense contractors. Aerial drones represent a $1.5 billion TAM in 2026, with next-generation drone platforms requiring higher energy density and strong discharge capabilities. Enovix is advancing its silicon anode technology to support these needs.
Financial Guidance for Q1 2026: Revenue is expected to range between $6.5 million and $7.5 million, reflecting seasonality and defense shipment timing. Non-GAAP loss from operations is projected between $29 million and $32 million. Capital expenditures are estimated between $9 million and $11 million, primarily for Fab2 equipment.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Share Repurchase Program: The Board authorized a share repurchase program, reflecting confidence in the company's long-term strategy and adding another tool to the capital allocation framework as the company focuses on long-term shareholder value.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:How does your current strategy differentiate Enovix from competitors?
A:Enovix uses 100% active silicon anode, unlike most competitors who use graphite. Silicon anodes store more lithium, providing higher energy density. Enovix has an architectural advantage to prevent silicon anode swelling while maintaining energy density.
Q:At our current burn rate, how long is our cash runway? And under what conditions will we need to raise additional capital?
A:Enovix ended the year with approximately $621 million in cash and marketable securities. The company ties spending to specific milestones, and they believe they have substantial liquidity to execute their strategy without needing to raise capital in the near term. They will evaluate capital allocation options opportunistically.
Q:In your engagements with Honor, how receptive were they to changing the 0.7C rate life cycle test requirement?
A:Honor and other smartphone customers understand that the 0.7C test is an accelerated proxy test and not a real-life test. Enovix is discussing three pathways: convincing customers to waive the 0.7C cycle life requirement, finding a more representative accelerated test, or modifying electrochemistry to pass the 0.7C test. Customers are interested in Enovix batteries due to their higher energy density.
Q:Should we think about the initial production demand for smart glasses as a purchase order? What is the revenue opportunity for 2026 or 2027?
A:Yes, the initial production demand is a purchase order. Enovix is manufacturing for their lead customer. Initial volumes will be lower, but the market is expected to grow significantly by 2027-2028.
Q:How are you addressing the electrode dicing and manufacturing process to improve yields?
A:Yields on most steps are above 80%, and dicing yields have reached 80% this quarter. Enovix is working on increasing throughput and exploring cost-effective dicing methods. Customers have audited the factories and are satisfied with the supply for 2026.
Q:What are the variations in chemistries for the drone market, and do you need additional salespeople to address it?
A:Enovix uses multiple chemistries, including silicon-doped and 100% silicon anodes, depending on the application. They are working on high-performance cells for drones, which can accommodate swelling. The company plans to expand its sales and business development team to support this market.
Q:What are your capital planning considerations for localized or regionalized supply in the Western Hemisphere?
A:Enovix currently manufactures in Korea and Malaysia, which is acceptable to customers. They are investing in the Korean facility to increase capacity and will evaluate the need for U.S. manufacturing based on customer requirements.
Q:What is the status of the 0.7C metric testing for the smartphone market?
A:The 0.7C test has always been a requirement. Enovix has solved the 0.2C real-use case but is working on resolving the 0.7C accelerated test through customer discussions, alternative tests, or electrochemistry modifications. They aim to resolve this by the end of the year.
Q:What are the main revenue drivers for the next six months, and how should we think about seasonality for defense?
A:Smart eyewear is the main revenue driver in the near term. Defense revenue tends to be soft in Q1 and stronger in the back half of the year, as evidenced by record Q4 revenue.
Q:What is the expected CapEx for the year?
A:Enovix has started placing orders for long-lead items for the HVM-2 line and will phase orders prudently throughout the year. Specific CapEx guidance beyond Q1 was not provided.
Q:What is the capacity of the Korean operations, and what investments are planned?
A:The Korean facility supports significantly higher revenue streams, potentially 2x current levels. Enovix is investing incrementally to scale capacity in a cost-effective manner.
Q:What are the key learnings from the smartphone chemistry reformulation process?
A:Smartphone requirements are stringent, and replacing graphite with silicon anodes requires adapting accelerated tests. Customers are motivated due to the energy density roadmap, and Enovix has made significant progress in meeting requirements.
Q:Does switching dicing technology reset the battery qualification process?
A:Switching dicing technology may require requalification, but equivalence can be established through subset testing. Enovix will work with customers to phase in changes gradually.
Q:Are there any remaining technical milestones for smart eyewear production?
A:Enovix has met the requirements for smart eyewear and received a production purchase order. The team is capable of quickly adapting to any new requirements.
Q:What is the cadence of testing and production for various markets?
A:Testing and production cycles vary by market. Smartphone testing can take 1-1.5 years, while markets like eyewear and drones have shorter cycles due to less stringent requirements. Custom cell development can extend timelines.
Q:What other markets can accommodate swelling batteries?
A:Industrial and defense markets, such as forklifts, can accommodate swelling due to larger space availability. Consumer markets like smart glasses and cameras are less forgiving.
Q:Review of Unclear Management Responses
A:Management avoided providing specific details on the megawatt-hour capacity of the Korean operations and the exact CapEx for the year. They also did not provide a clear timeline for resolving the 0.7C metric testing for smartphones, as it depends on customer discussions and potential changes to testing protocols.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
OEMs market
adoption
apple
battery TAM
capability
commercialization pathway
consumption
contractor
cycle durability
cycle rate
cycle test
decade
defense cell
density architecture
density flight
device eyewear
drone application
drone platform
durability threshold
engagement
experience consumer
eyewear commercialization
focus
generation silicon
life requirement
life testing
mix
munition
pathway qualification
platform energy
power demand
protocol
requirement cycle
scenario
segment
shipment
smartphone qualification
system
use
validation
ENVX Transcript
Enovix Corporation (ENVX) Q4 2025 Earnings Call Transcript
Positive2-26
The earnings call reveals strong financial metrics and optimistic guidance, particularly with a 25% revenue increase expected and significant market expansion in smartphones, smart eyewear, and defense. Despite some uncertainties in the Q&A, like the 0.7C test for smartphones, the overall sentiment is positive due to new product launches, strategic partnerships, and manufacturing optimizations. The market cap suggests moderate sensitivity, leading to a positive prediction of stock movement between 2% to 8%.
Enovix Corporation (ENVX) Q3 2025 Earnings Call Transcript
Positive11-6
The earnings call summary shows optimistic guidance with revenue growth, market expansion, and a strategic focus on technology improvements, which are positive indicators. The Q&A section reveals confidence in product development and partnerships, particularly with Honor, and strong financial health. The market cap suggests a moderate reaction, but the positive earnings call and Q&A insights lead to a likely stock price increase of 2% to 8% over the next two weeks.
Enovix Corporation (ENVX) Q2 2025 Earnings Call Transcript
Unknown8-1
The earnings call reveals mixed signals. Positive aspects include exceeding Q1 revenue guidance and strategic expansions, such as the acquisition in Korea and new product developments. However, the guidance for Q2 indicates substantial operating and EBITDA losses, and management's reluctance to provide clear timelines or volumes raises concerns. While there is potential for growth in new markets, the lack of clarity and the projected losses suggest a neutral sentiment, with no strong catalysts to drive a significant stock price change in the short term.
Enovix Corporation (NASDAQ:ENVX) Q1 2025 Earnings Call Transcript
Unknown5-6
The earnings call presents a mixed picture. Revenue exceeded guidance, but financial losses remain high, affecting investor sentiment. The absence of a share repurchase program and competitive pressures add concerns. However, positive developments in product advancements and strategic positioning in supply chains provide optimism. The Q&A session highlights progress but also reveals some uncertainties. Given the mixed nature of the information and the company's small market cap, the stock is likely to experience neutral movement within the -2% to 2% range over the next two weeks.
ENVX Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
